Works matching IS 15747891 AND DT 2022 AND VI 16 AND IP 6

Results: 11

microRNA-99a-5p induces cellular senescence in gemcitabine-resistant bladder cancer by targeting SMARCD1.
Published in:
Molecular Oncology, 2022, v. 16, n. 6, p. 1329, doi. 10.1002/1878-0261.13192
By:
- Motoki Tamai;
- Shuichi Tatarano;
- Shunsuke Okamura;
- Wataru Fukumoto;
- Issei Kawakami;
- Yoichi Osako;
- Takashi Sakaguchi;
- Satoshi Sugita;
- Masaya Yonemori;
- Yasutoshi Yamada;
- Masayuki Nakagawa;
- Hideki Enokida;
- Hirofumi Yoshino
Publication type:
Article
Ex vivo drug sensitivity screening in multiple myeloma identifies drug combinations that act synergistically.
Published in:
Molecular Oncology, 2022, v. 16, n. 6, p. 1241, doi. 10.1002/1878-0261.13191
By:
- Giliberto, Mariaserena;
- Thimiri Govinda Raj, Deepak B.;
- Cremaschi, Andrea;
- Skånland, Sigrid S.;
- Gade, Alexandra;
- Tjønnfjord, Geir E.;
- Schjesvold, Fredrik;
- Munthe, Ludvig A.;
- Taskén, Kjetil
Publication type:
Article
A new function for the serine protease HtrA2 in controlling radiation-induced senescence in cancer cells.
Published in:
Molecular Oncology, 2022, v. 16, n. 6, p. 1365, doi. 10.1002/1878-0261.13187
By:
- Hammer, Liat;
- Levin-Salomon, Vered;
- Yaeli-Slonim, Naama;
- Weiss, Moria;
- Dekel-Bird, Naama P.;
- Olender, Tsviya;
- Porat, Ziv;
- Winograd-Katz, Sabina;
- Savidor, Alon;
- Levin, Yishai;
- Bialik, Shani;
- Geiger, Benjamin;
- Kimchi, Adi
Publication type:
Article
miR-200a/b/-429 downregulation is a candidate biomarker of tumor radioresistance and independent of hypoxia in locally advanced cervical cancer.
Published in:
Molecular Oncology, 2022, v. 16, n. 6, p. 1402, doi. 10.1002/1878-0261.13184
By:
- Nilsen, Anja;
- Hillestad, Tiril;
- Skingen, Vilde E.;
- Aarnes, Eva-Katrine;
- Fjeldbo, Christina S.;
- Hompland, Tord;
- Sandø Evensen, Tina;
- Stokke, Trond;
- Kristensen, Gunnar B.;
- Grallert, Beata;
- Lyng, Heidi
Publication type:
Article
p53 mutations define the chromatin landscape to confer drug tolerance in pancreatic cancer.
Published in:
Molecular Oncology, 2022, v. 16, n. 6, p. 1259, doi. 10.1002/1878-0261.13161
By:
- Zampieri, Carlotta;
- Panatta, Emanuele;
- Corbo, Vincenzo;
- Mauriello, Alessandro;
- Melino, Gerry;
- Amelio, Ivano
Publication type:
Article
FGF7--FGFR2 autocrine signaling increases growth and chemoresistance of fusion-positive rhabdomyosarcomas.
Published in:
Molecular Oncology, 2022, v. 16, n. 6, p. 1272, doi. 10.1002/1878-0261.13145
By:
- Milton, Christopher I.;
- Selfe, Joanna;
- Aladowicz, Ewa;
- Man, Stella Y. K.;
- Bernauer, Carolina;
- Missiaglia, Edoardo;
- Walters, Zoë S.;
- Gatz, Susanne A.;
- Kelsey, Anna;
- Generali, Melanie;
- Box, Gary;
- Valenti, Melanie;
- de Haven-Brandon, Alexis;
- Galiwango, David;
- Hayes, Angela;
- Clarke, Matthew;
- Izquierdo, Elisa;
- Gonzalez De Castro, David;
- Raynaud, Florence I.;
- Kirkin, Vladimir
Publication type:
Article
PELI1 promotes radiotherapy sensitivity by inhibiting noncanonical NF-κB in esophageal squamous cancer.
Published in:
Molecular Oncology, 2022, v. 16, n. 6, p. 1384, doi. 10.1002/1878-0261.13134
By:
- Dongfang Dai;
- Hongping Zhou;
- Li Yin;
- Fei Ye;
- Xiao Yuan;
- Tao You;
- Xiaohui Zhao;
- Weiguo Long;
- Deqiang Wang;
- Xia He;
- Jifeng Feng;
- Deyu Chen
Publication type:
Article
Lung cancer cells expressing a shortened CDK16 3'UTR escape senescence through impaired miR-485-5p targeting.
Published in:
Molecular Oncology, 2022, v. 16, n. 6, p. 1347, doi. 10.1002/1878-0261.13125
By:
- Qi Jia;
- Baiyun Xie;
- Zhaozhao Zhao;
- Leihuan Huang;
- Gang Wei;
- Ting Ni
Publication type:
Article
Intrinsic and acquired drug resistance to LSD1 inhibitors in small cell lung cancer occurs through a TEAD4-driven transcriptional state.
Published in:
Molecular Oncology, 2022, v. 16, n. 6, p. 1309, doi. 10.1002/1878-0261.13124
By:
- Wen Yan;
- Chi-Yeh Chung;
- Tao Xie;
- Ozeck, Mark;
- Nichols, Timothy C.;
- Frey, Jessica;
- Udyavar, Akshata R.;
- Sharma, Shikhar;
- Paul, Thomas A.
Publication type:
Article
A novel anti-c-Kit antibody--drug conjugate to treat wild-type and activating-mutant c-Kit-positive tumors.
Published in:
Molecular Oncology, 2022, v. 16, n. 6, p. 1290, doi. 10.1002/1878-0261.13084
By:
- Jin-Ock Kim;
- Kwang-Hyeok Kim;
- Eun Ji Baek;
- Bomi Park;
- Min Kyung So;
- Byoung Joon Ko;
- Han-Jik Ko;
- Sang Gyu Park
Publication type:
Article
Desmoglein-2 expression is an independent predictor of poor prognosis patients with multiple myeloma.
Published in:
Molecular Oncology, 2022, v. 16, n. 6, p. 1221, doi. 10.1002/1878-0261.13055
By:
- Ebert, Lisa M.;
- Vandyke, Kate;
- Johan, M. Zahied;
- DeNichilo, Mark;
- Lih Y. Tan;
- Min, Kay K. Myo;
- Weimann, Benjamin M.;
- Ebert, Brenton W.;
- Pitson, Stuart M.;
- Zannettino, Andrew C. W.;
- Wallington-Beddoe, Craig T.;
- Bonder, Claudine S.
Publication type:
Article